* iSpecimen Inc ISPC.OQ ISPC.O is expected to show a
rise in
quarterly revenue when it reports results on March 13 for the
period ending December 31 2023
* The Lexington Massachusetts-based company is expected to
report
a 2.7% increase in revenue to $3.041 million from $2.96 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for iSpecimen Inc is for a
loss
of 24 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for iSpecimen
Inc is
$5.00, above its last closing price of $0.41.
This summary was machine generated March 11 at 13:10 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)